TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors (Q37352827)

19 August 2017

1 reference

title

TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors (English)

1 reference

19 August 2017

Cristina Maccalli

1

1 reference

PubMed ID

19089424

19 August 2017

Samantha Scaramuzza

series ordinal

2

1 reference

PubMed ID

19089424

19 August 2017

Giorgio Parmiani

series ordinal

3

1 reference

19 August 2017

17 December 2008

1 reference

Cancer Immunology, Immunotherapy

19 August 2017

1 reference

19 August 2017

58

1 reference

19 August 2017

801-808

1 reference

19 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-008-0635-x

19 August 2017

0 references

cites work

Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0635-X

Molecular regulation of MHC class I chain-related protein A expression after HDAC-inhibitor treatment of Jurkat T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0635-X

In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0635-X

Human tumor-derived exosomes down-modulate NKG2D expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0635-X

Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0635-X

The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0635-X

Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0635-X

Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0635-X

Going both ways: immune regulation via CD1d-dependent NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0635-X

Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0635-X

Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0635-X

IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0635-X

Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0635-X

Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0635-X

10.1007/S00262-008-0635-X

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

19089424